Checklist for Valuing Healthcare Companies in M&A Deals

Healthcare valuations combine standard financial diligence with sector-specific regulatory and payer risk. Getting the financial preparation right before entering the market is the foundation for a defensible valuation.

Financial Preparation

Gather audited or reviewed financial statements for the last 3–5 years, revenue broken down by payer type (Medicare, Medicaid, commercial insurance, self-pay) and by provider or CPT code, and detailed A/R aging reports—since aging beyond 60 days is a major concern for healthcare buyers. A Quality of Earnings analysis then normalizes EBITDA by identifying add-backs like personal perks or one-time legal settlements, each of which must be well documented since buyers will challenge anything that looks dubious.

Payer Mix and Accounts Receivable

If more than 30% of revenue comes from a single payer, buyers may see that as a risk factor. Healthy practices generally keep receivables aged over 90 days below 10–15%. Because healthcare companies are often valued at a multiple of EBITDA, even small revenue swings matter: at a 10x multiple, a 2% revenue variance on $5 million in revenue can shift EBITDA enough to move the deal price by roughly $1 million.

Choosing a Valuation Method

EBITDA multiples are the most common approach: primary care practices generally trade at 4–7x EBITDA, while specialty practices often see 6–12x, and practices above $3 million in EBITDA can achieve up to 80% higher multiples than those under $1 million. Discounted cash flow works for businesses with stable, recurring revenue but is rarely used alone in healthcare. Asset-based valuation fits operations reliant on physical infrastructure—imaging centers, surgery centers, skilled nursing facilities—and is also the approach that complies with Stark Law and the Anti-Kickback Statute when an ongoing referral relationship exists.

Healthcare-Specific Risk Adjustments

Buyers scrutinize compliance with the Anti-Kickback Statute and Stark Law—violations have led to settlements exceeding $30 million—along with physician compensation at fair market value, OIG exclusion checks, and Change of Ownership requirements for Medicare and state licenses. Clinical quality metrics like readmission rates, Medicare Star Ratings, and workforce stability also factor into the price buyers are willing to pay.

Final Review and Presentation

Cross-check results across the market, income, and asset approaches, and run sensitivity analyses on EBITDA, multiples, and reimbursement rates. A CIM or OM typically runs 50 to 150 pages and should document compliance with Stark Law, the Anti-Kickback Statute, and HIPAA alongside investment highlights. Healthcare valuations generally take 4–8 weeks and cost $15,000 to $75,000-plus when done by outside advisors.

• Collect 3–5 years of audited financials and run a Quality of Earnings analysis
• Analyze payer mix and A/R aging for concentration and collection risk
• Select EBITDA multiples, DCF, or asset-based valuation based on the business model
• Address Stark Law, Anti-Kickback Statute, and OIG exclusion risk before going to market
• Cross-check valuation methods and stress-test assumptions before presenting to buyers